Accrual continues to be a challenge for oncology clinical trials. Interventions to enhance accrual after study activation exist, including corrective action plans for NCI-sponsored trials. Clinical trials would benefit from a proactive approach rather than a reactive approach. Accrual strategy planning early in trial development is suggested. Clin Cancer Res; 22(22); 5397–9. ©2016 AACR.
See related article by Massett et al., p. 5408
- Received July 27, 2016.
- Accepted August 5, 2016.
- ©2016 American Association for Cancer Research.